Intestinal Cell News 4.32 August 24, 2018 | |
| |
TOP STORYInteraction between Smoking and ATG16L1T300A Triggers Paneth Cell Defects in Crohn’s Disease Investigators found that both Crohn’s disease subjects and mice with ATG16L1T300A developed Paneth cell defects triggered by tobacco smoke. [J Clin Invest] Abstract | Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Overexpression of TRIM27 promoted cancer cell growth in vitro and tumor growth in nude mice, whereas knockdown of TRIM27 had opposite effects. [Nat Commun] Full Article Intrinsic Xenobiotic Resistance of the Intestinal Stem Cell Niche Scientists found that intestinal myofibroblasts are intrinsically resistant to multiple xenobiotics, including PORCN inhibitors and the anthracycline antibiotic doxorubicin. These myofibroblasts had high expression of a subset of drug transporters; knockout of Mrp1/Abcc1 enhanced drug sensitivity. [Dev Cell] Abstract | Press Release | Graphical Abstract Investigators developed a two-step protocol in which mesenchymal stem cells were first induced into Sox17- or Foxa2-positive definitive endoderm cells by activin A treatment and then into Lgr5-positive intestinal stem cell-like cells by miR-17 and FGF2 treatment. [Mol Ther Nucleic Acids] Abstract | Full Article Scientists showed that Fas in its pro-survival state, phosphorylated at Y291, functionally interacts with the epidermal growth factor receptor (EGFR), a key cancer-driving protein and major therapeutic target. [Sci Rep] Full Article Researchers generated intestinal epithelial cells from human induced pluripotent stem cells and then clarified whether the functions of hydrolase and transporters in them reflect oral drug absorption in the small intestine. [Drug Metab Dispos] Abstract | Full Article The authors showed that luteolin suppressed cell proliferation and cellular transformation of HCT116 and HT29 cells in a dose‐dependent manner. [J Cell Biochem] Abstract Crocin suppressed cell‐growth and the invasive behavior of colorectal cancer cells through modulation of the Wnt‐pathway and E‐cadherin. Moreover, administration of crocin alone, or in combination with 5-fluorouracil dramatically reduced the tumor number and tumor size in both distal/mid‐colon followed by reduction in disease‐activity index. [J Cell Biochem] Abstract Apelin Effects Migration and Invasion Abilities of Colon Cancer Cells Researchers showed that the effect of four different apelin peptides increased the ability of cancer cells to migrate and invade examined cells through influencing migratory protrusions formation and actin cytoskeleton rearrangement. [Cells] Full Article Scientists determined the effect of peroxynitrite on Na-glucose co-transport and Na/H exchange in small intestinal epithelial cell monolayers grown on trans well plates. [Cells] Full Article Subscribe to one of our other 19 science newsletters such as Pulmonary Cell News & ESC & iPSC News. | |
| |
REVIEWSReserve Stem Cells in Intestinal Homeostasis and Injury The authors review models used to study the mechanisms by which intestinal stem cells fuel the rapid turnover of the epithelium during homeostasis and might support epithelial regeneration after injury. [Gastroenterology] Abstract Visit our reviews page to see a complete list of reviews in the intestinal cell research field. | |
| |
INDUSTRY NEWSTelix Pharmaceuticals, University of Melbourne and Peter Mac to Collaborate on Colorectal Cancer Telix Pharmaceuticals Limited announced a research collaboration with the University of Melbourne to investigate the use of targeted radiopharmaceuticals or “molecularly-targeted radiation” to provide improved treatments for colorectal cancer patients. [Telix Pharmaceuticals (GlobeNewswire, Inc)] Press Release Innovate Biopharmaceuticals, Inc. announced it signed an agreement with Amarex Clinical Research to provide data management and biostatistics for its planned Phase III celiac disease trial. [Innovate Biopharmaceuticals, Inc.] Press Release Approval of Linzess® Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation Astellas Pharma Inc. and Ironwood Pharmaceuticals, Inc. announced that approval has been obtained in Japan for the guanylate cyclase-C receptor agonist Linzess® tablets for the additional indication of chronic constipation. [Astellas Pharma Inc.] Press Release | |
| |
| |
POLICY NEWSEurope’s First Allogeneic Stem Cell Therapy Rejected by NICE Cost regulators for the NHS in England and Wales have not approved funding for TiGenix and Takeda’s Alofisel – the first allogeneic stem cell therapy to be approved for use across the European Union – for use in Crohn’s patients. [PharmaTimes] Editorial Senate Approves $2B Boost for NIH in $850B+ Spending Bill For the fourth year in a row, the Senate has approved a significant increase in funding for the National Institutes of Health (NIH). [Fierce Biotech] Editorial The National Institutes of Health (NIH) is investigating roughly a half-dozen research institutions based on suspicions that researchers with federal grants failed to disclose significant financial contributions from foreign governments. [STAT News] Editorial
| |
EVENTSNEW Lorne Cancer Conference 2019 Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW PhD Student – Colorectal Cancer (German Cancer Research Center) Postdoctoral Scholar – Intestinal Research (Penn State College of Medicine) Postdoctoral Fellow – Signal Transduction of Intestinal Cells (Mornell Chemical Senses Center) Postdoctoral Fellow – Colon Cancer (Vanderbilt University Medical Center) Postdoctoral Position – Paneth Cells (Erasmus MC Cancer Institute) Postdoctoral Scholar – Molecular and Cell Biology (University of California, Berkeley) Assistant Professor – Cancer Biology (Université de Genève) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Intestinal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|